Cargando…

Excited‐State Dynamics of a Two‐Photon‐Activatable Ruthenium Prodrug

We present a new approach to investigate how the photodynamics of an octahedral ruthenium(II) complex activated through two‐photon absorption (TPA) differ from the equivalent complex activated through one‐photon absorption (OPA). We photoactivated a Ru(II) polypyridyl complex containing bioactive mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenough, Simon E., Horbury, Michael D., Smith, Nichola A., Sadler, Peter J., Paterson, Martin J., Stavros, Vasilios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797363/
https://www.ncbi.nlm.nih.gov/pubmed/26632426
http://dx.doi.org/10.1002/cphc.201501075
Descripción
Sumario:We present a new approach to investigate how the photodynamics of an octahedral ruthenium(II) complex activated through two‐photon absorption (TPA) differ from the equivalent complex activated through one‐photon absorption (OPA). We photoactivated a Ru(II) polypyridyl complex containing bioactive monodentate ligands in the photodynamic therapy window (620–1000 nm) by using TPA and used transient UV/Vis absorption spectroscopy to elucidate its reaction pathways. Density functional calculations allowed us to identify the nature of the initially populated states and kinetic analysis recovers a photoactivation lifetime of approximately 100 ps. The dynamics displayed following TPA or OPA are identical, showing that TPA prodrug design may use knowledge gathered from the more numerous and easily conducted OPA studies.